Learning Curve for Laparoscopic Distal Pancreatectomy

December 10, 2010 updated by: Università Vita-Salute San Raffaele

Learning Curve for Laparoscopic Distal Pancreatectomy in a High-volume Hospital

Laparoscopic distal pancreatectomy (LDP) for benign and borderline pancreatic lesions has recently becoming the treatment of choice in experienced centres. No data have been published about learning curve so far. The purpose of this study was to identify the learning curve period for performing LDP.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Between March 2009 and August 2010 all patients with lesion of body or tail of pancreas were assessed for eligibility for LDP. Exclusion criteria were: major vessels contact in cancer patients, severe organ dysfunction, BMI > 35, and refusing laparoscopic approach. All laparoscopic procedures were carried out by the same surgical team with large experience in open pancreatic surgery. All patients were treated according to an early recovery after surgery protocol. Primary endpoint was conversion rate. Secondary endpoints were operation time, operative blood loss, postoperative morbidity, and length of stay.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Milan, Italy, 20132
        • San Raffaele Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • pancreatic lesion located at body or tail

Exclusion Criteria:

  • major vessels infiltration
  • severe organ dysfunction
  • refusing laparoscopic approach

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Laparoscopic Distal Pancreatectomy
Laparoscopic distal pancreatectomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Conversion to open surgery
Time Frame: during surgery; 3 to 5 hours from the start of the procedure
during surgery; 3 to 5 hours from the start of the procedure

Secondary Outcome Measures

Outcome Measure
Time Frame
Operative Time
Time Frame: during surgery; 3 to 5 hours from the start of the procedure
during surgery; 3 to 5 hours from the start of the procedure
Blood loss
Time Frame: during surgery; 3 to 5 hours from the start of the procedure
during surgery; 3 to 5 hours from the start of the procedure
Length of Hospital Stay
Time Frame: Postoperative. From 0 to 30 days after discharge.
Postoperative. From 0 to 30 days after discharge.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2009

Primary Completion (Actual)

August 1, 2010

Study Completion (Actual)

August 1, 2010

Study Registration Dates

First Submitted

December 10, 2010

First Submitted That Met QC Criteria

December 10, 2010

First Posted (Estimate)

December 13, 2010

Study Record Updates

Last Update Posted (Estimate)

December 13, 2010

Last Update Submitted That Met QC Criteria

December 10, 2010

Last Verified

August 1, 2010

More Information

Terms related to this study

Other Study ID Numbers

  • PANCREAS-LDP2010

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pancreatic Lesions Located at Body or Tail.

Clinical Trials on Laparoscopy

Subscribe